Anika Therapeutics, Inc. (ANIK)

NASDAQ: ANIK · Real-Time Price · USD

18.07

+1.90 (11.75%)

At close: Jul 30, 2026, 4:00 PM EDT

18.07

0.00 (0.00%)

After-hours: Jul 30, 2026, 4:01 PM EDT

Anika Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	120.65	112.82	119.91	120.79	113.83	147.79
Revenue Growth	5.33%	-5.91%	-0.73%	6.12%	-22.98%	13.29%
Gross Profit	75	63.81	76	82.53	73.22	82.94
Operating Income	-5.12	-11.05	-5.1	0.84	3.67	2.62
Net Income	-3.78	-10.88	-56.39	-82.67	-14.86	4.13
Earnings Per Share	-0.17	-0.70	-0.60	-0.23	0.15	0.28
EPS Growth	-	-	-	-	-46.43%	-

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	70.06	82.45	86.91	83.75	113.83
Europe	22.21	19.4	17.31	17.23	19.58
Other	20.55	18.06	16.57	12.85	14.38
Total	112.82	119.91	120.79	113.83	147.79

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	38.41	57.48	55.63	68.74	86.33	94.39
Total Debt	23.32	24.2	24.01	25.92	28.82	19.24
Net Cash (Debt)	15.1	33.29	31.62	42.83	57.51	75.15
Net Cash Growth	-49.67%	5.28%	-26.18%	-25.54%	-23.47%	-2.96%
Net Cash Per Share	1.07	2.32	2.15	2.92	3.89	5.14

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	5.98	11.19	5.4	-1.79	4.41	8.4
Capital Expenditures	-5.42	-6.83	-7.73	-5.43	-7.49	-5.14
Free Cash Flow	0.56	4.36	-2.33	-7.22	-3.08	3.25
Free Cash Flow Growth	-	-	-	-	-	-71.55%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	62.16%	56.56%	63.38%	68.33%	64.33%	56.12%
Operating Margin	-4.24%	-9.80%	-4.25%	0.70%	3.22%	1.77%
Pretax Margin	-2.41%	-8.25%	-2.31%	2.61%	3.80%	1.64%
Profit Margin	-2.59%	-8.85%	-7.36%	-2.85%	1.93%	2.80%
FCF Margin	0.47%	3.87%	-1.94%	-5.97%	-2.70%	2.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	197.33	127.96
Forward PE	-	53.39	39.19	72.08	72.08	112.55
P/FCF Ratio	432.08	30.60	-	-	-	159.01
PS Ratio	2.01	1.18	1.98	2.75	3.80	3.50